Curcumin inhibits growth of human breast cancer cells through demethylation of DLC1 promoter

Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1

(2015) Yue Guo et al.   BIOCHEMICAL PHARMACOLOGY

Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer

(2015) Lewis Quayle et al.   CURRENT CANCER DRUG TARGETS

Sp1 and the ‘hallmarks of cancer’

(2015) Kate Beishline et al.   FEBS Journal

Sp1 transcription factor: A long-standing target in cancer chemotherapy

(2015) Carolina Vizcaíno et al.   PHARMACOLOGY & THERAPEUTICS

DNMT1 is essential for mammary and cancer stem cell maintenance and tumorigenesis

(2015) Rajneesh Pathania et al.   Nature Communications

Epidermal Growth Factor Activates the Rho GTPase-activating Protein (GAP) Deleted in Liver Cancer 1 via Focal Adhesion Kinase and Protein Phosphatase 2A

(2014) Archna Ravi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

DLC1-dependent parathyroid hormone–like hormone inhibition suppresses breast cancer bone metastasis

(2014) Yufeng Wang et al.   JOURNAL OF CLINICAL INVESTIGATION

Deleted in Liver Cancer-1 (DLC1): An Emerging Metastasis Suppressor Gene

(2014) Nicholas C. Popescu et al.   Molecular Diagnosis & Therapy

Curcumin: A Potential Candidate in Prevention of Cancer via Modulation of Molecular Pathways

(2014) Arshad H. Rahmani et al.   Biomed Research International

Curcumin Modulates DNA Methylation in Colorectal Cancer Cells

(2013) Alexander Link et al.   PLoS One

Epigenetic changes induced by curcumin and other natural compounds

(2011) Simone Reuter et al.   Genes and Nutrition

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma

(2011) Reason Wilken et al.   Molecular Cancer

A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors

(2011) J S W Low et al.   ONCOGENE

Transcriptional Repressive H3K9 and H3K27 Methylations Contribute to DNMT1-Mediated DNA Methylation Recovery

(2011) Chun-Ming Wong et al.   PLoS One

Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK)

(2011) G. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The role of Sp1 and Sp3 in normal and cancer cell biology

(2010) Lin Li et al.   ANNALS OF ANATOMY-ANATOMISCHER ANZEIGER

Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach

(2010) Jose L. Medina-Franco et al.   MOLECULAR DIVERSITY

Molecular mechanisms of metastasis in breast cancer—clinical applications

(2010) Michal Mego et al.   Nature Reviews Clinical Oncology

Challenges, controversies, breakthroughs

(2010) Lisa Hutchinson   Nature Reviews Clinical Oncology

Curcumin and Cancer Cells: How Many Ways Can Curry Kill Tumor Cells Selectively?

(2009) Jayaraj Ravindran et al.   AAPS Journal

Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications

(2009) G. Bar-Sela et al.   CURRENT MEDICINAL CHEMISTRY

Linking DNA methylation and histone modification: patterns and paradigms

(2009) Howard Cedar et al.   NATURE REVIEWS GENETICS

Curcumin is a potent DNA hypomethylation agent

(2008) Zhongfa Liu et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Rho GTPases in cancer cell biology

(2008) Francisco M. Vega et al.   FEBS LETTERS